Based on presentations and other announcments, they are going to be well and truly cashflow + for the next few years which will give them plenty of time to execute product development. The royalty income stream + $190m @ 0.07 is good cash. I see this as a low risk play.
AAH
arana therapeutics limited
mkt cap 100m below owners equity, page-6
Add to My Watchlist
What is My Watchlist?